The first group received continuous combined oral HRT containing @mg @-estradiol and @ mg norethisterone acetate ( n = @ ) , and the second group received sequential transdermal HRT releasing @g/day estradiol alone given twice a week on days @-@ and @g/day estradiol plus @ mg/day norethisterone acetate given twice a week on days @-@ ( n = @ ) .